EU Rejections and Setbacks for Duchenne Muscular Dystrophy Gene Therapies
European regulators have decided not to approve the Duchenne muscular dystrophy gene therapy Elevidys, adding to global safety concerns and halting its distribution in Japan and Brazil, with ongoing investigations into safety issues.